Asthma Market is expected to boost the growth of the market over the forecast period.
Asthma Market size such as the patent expiry of drugs, high expenditure on treatment, and growth in the use of generic drugs. The global Asthma Market size spans type, device type, drug type, route of administration, and geography. Based on type, the global Asthma Market size constitutes allergic asthma and non-allergic asthma. Allergic asthma is caused due to exposure to allergens like pollens from weeds, trees, etc., dust, and so on. On the other hand, non-allergic asthma is caused due to exercise, stress, cold, flu, etc.
Download Free Sample - https://www.millioninsights.com/industry-reports/asthma-market/request-sample
Based on device type, the global Asthma Market size constitutes inhalers and nebulizers. The “inhalers” segment is further sub-categorized as dry powder, soft mist inhalers (SMIs), metered-dose inhalers (MDIs). Nebulizers are devices that carry the drug in a fluid form that is dispensed by compressed air. The “nebulizers” segment is further sub-categorized as mesh nebulizers, compressor nebulizers, and ultrasonic nebulizers. In 2015, the metered-dose inhalers (MDIs) accounted for the largest share of the global Asthma Market owing to the ease of availability, consistency, portability, flexibility, and cost-effectiveness.
The features like portability, noteworthy benefits in the home healthcare applications, and ideal design that enables dispensing medication directly to the respiratory tract are estimated to offer prospective growth opportunities for its high utility. Based on drug type, the global Asthma Market size spans anti-inflammatory, immunosuppressant, bronchodilators, mast cell stabilizers, leukotriene antagonists, and a combination of ICS/LABA. In this segmentation, the combination drug type consisting of inhaled corticosteroids with long-acting beta-agonists dominated the global Asthma Market in 2015. The factors that attribute to the large share of combination drug types are the rise in application rates due to the twofold action of combination therapy and its high efficacy rate.
Comments
Post a Comment